Our results revealed that PCAT6 was upregulated in lung cancer tissues and cells, which was induced by sevoflurane, and overexpression of PCAT6 inverted the sevoflurane’s repression on viability, proliferation, invasion, and promotion on apoptosis of human lung cancer cells in vitro. This evidence concerns the gene PCAT6 and lung carcinoma.